Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dry AMD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT05418231
What this trial is testing

Observation of the Natural Course of Age-related Macular Degeneration

Who this might be right for
Dry Age-related Macular DegenerationMacular Degeneration, Dry
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 500
Early research (Phase 1)Study completedNCT02130531
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular Degeneration

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
Kubota Vision Inc. 26
Large-scale testing (Phase 3)Study completedNCT01802866
What this trial is testing

Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride

Who this might be right for
Geographic Atrophy
Kubota Vision Inc. 508
Early research (Phase 1)Study completedNCT01013376
What this trial is testing

A Pilot Study of the Safety of MC-1101 in Both Normal Volunteers and Patients With Early Dry AMD

Who this might be right for
Age-Related Macular Degeneration
MacuCLEAR, Inc. 31
Not applicableStudy completedNCT04522999
What this trial is testing

Study of Photobiomodulation Effect on Electroretinogram Outcomes in Dry Age-Related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
LumiThera, Inc. 15
Not applicableStudy completedNCT03753893
What this trial is testing

Ocular Manifestations in Rheumatic Diseases

Who this might be right for
UveitisConjunctivitisKeratoconjunctivitis Sicca+15 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 5,000
Early research (Phase 1)Study completedNCT03144999
What this trial is testing

Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59

Who this might be right for
Dry Age-related Macular Degeneration
Janssen Research & Development, LLC 17
Post-approval studies (Phase 4)Study completedNCT05269966
What this trial is testing

Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Novartis Pharmaceuticals 105
Early research (Phase 1)Study completedNCT00950638
What this trial is testing

ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration

Who this might be right for
Dry Age-Related Macular Degeneration
Ophthotech Corporation 47
Not applicableEnded earlyNCT03894020
What this trial is testing

GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)

Who this might be right for
Dry Age-related Macular DegenerationMacular DegenerationRetinal Disease+3 more
Gyroscope Therapeutics Limited 83
Large-scale testing (Phase 3)Study completedNCT02686658
What this trial is testing

Zimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Who this might be right for
Geographic AtrophyDry Age-Related Macular Degeneration
IVERIC bio, Inc. 286
Large-scale testing (Phase 3)Looking for participantsNCT07770828
What this trial is testing

Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic Atrophy Secondary to Dry AMD

Who this might be right for
Dry Age-related Macular Degeneration
Ocugen 237
Post-approval studies (Phase 4)Study completedNCT04679935
What this trial is testing

Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 52
Post-approval studies (Phase 4)Study completedNCT01775124
What this trial is testing

Efficacy and Safety of Ranibizumab 0.5 mg Administered as Two Alternative Dosing Regimens in Chinese Patients With nAMD (Age Related Macular Degeneration)

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 332
Not applicableStudy completedNCT01840683
What this trial is testing

HELP Therapy for Dry AMD

Who this might be right for
Non-exudative (Dry) Age-related Macular Degeneration (AMD)
B.Braun Avitum AG 22
Not applicableNot Yet RecruitingNCT07409389
What this trial is testing

Repeated Low-Level Red-Light Therapy in Dry Age-Related Macular Degeneration

Who this might be right for
AMD - Age-Related Macular Degeneration
The Hong Kong Polytechnic University 94
Testing effectiveness (Phase 2)Study completedNCT01527500
What this trial is testing

Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)

Who this might be right for
Geographic AtrophyAge-related Macular Degeneration
Novartis Pharmaceuticals 158
Testing effectiveness (Phase 2)Looking for participantsNCT06557460
What this trial is testing

A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)

Who this might be right for
Dry Age-related Macular DegenerationGeographic Atrophy
Regenerative Patch Technologies, LLC 24
Not applicableStudy completedNCT07424235
What this trial is testing

Evaluating the Relationship Between Function and Structure Using Data From a GA Natural History Cohort

Who this might be right for
Age Related Macular Degeneration (AMD)Age Related Macular DegenerationAMD+3 more
IRCCS Ospedale San Raffaele 60
Post-approval studies (Phase 4)Study completedNCT04774926
What this trial is testing

Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 122
Next Page